Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole versus placebo for acute mania in bipolar I disorder
2017-002222-20Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Brexpiprazole with Placebo (2 arms). Primary endpoint: Change from baseline to Day 21 in YMRS total score. Started Nov 2017; status: completed.
02
Drugs
brexpiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2017-002222-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002222-20.